Mar 01, 2019 - Jefferies' equity strategist Steven DeSanctis warned investors of the darling stocks the most active funds own.
Feb 19, 2019 - AFM13 data at ASH proved deepening and durable for relapsed & refractory Hodgkin's Lymphoma.Data compares favorably to existing salvage therapies and opens the door for accelerated approval.At a R&D d
Feb 12, 2019 - Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated CD30+ stage IV cHL.
Feb 11, 2019 - Margetuximab has blockbuster potential boding well for MacroGenics as the data support initiation of a head to head trial in the first line.Yet again, the analysts were wrong.A wealth of preclinical a
Feb 08, 2019 - Seattle Genetics (SGEN) incurs wider-than-expected loss in Q4 but rides high on revenue beat.
Feb 08, 2019 -
Feb 08, 2019 - SGEN earnings call for the period ending December 31, 2018.
Feb 08, 2019 -
The following are top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs Feb. 7.)
Feb 08, 2019 - Today's Top Stories: Trump's China caution deflates investors on edge over trade; Trump to ban China telecom equipment over cyber threats; and Jeff Bezos accuses National Enquirer of blackmail. If you
Feb 08, 2019 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). U.S. stock futures point to additional loss